CARDIAC NORADRENALINE RELEASE ACCELERATES ADENOSINE FORMATION IN THE ISCHEMIC RAT-HEART - ROLE OF NEURONAL NORADRENALINE CARRIER AND ADRENERGIC-RECEPTORS
G. Richardt et al., CARDIAC NORADRENALINE RELEASE ACCELERATES ADENOSINE FORMATION IN THE ISCHEMIC RAT-HEART - ROLE OF NEURONAL NORADRENALINE CARRIER AND ADRENERGIC-RECEPTORS, Journal of Molecular and Cellular Cardiology, 26(10), 1994, pp. 1321-1328
In the present study the hypothesis was tested that local noradrenalin
e release contributes to adenosine formation in myocardial ischemia. T
herefore, in ischemic nonworking rat hearts either adrenergic receptor
s or ischemia-evoked noradrenaline release were blocked. Noradrenaline
and adenosine were determined in the effluent using HPLC-methods. Fol
lowing 20 min of stop of perfusion flow both the P-adrenergic receptor
antagonist bisoprolol (91.6 +/- 10.5 nmol/g) and the inhibitor of isc
hemia-induced noradrenaline release desipramine (108.5 +/- 12.5 nmol/g
) caused a suppression of adenosine release (control: 140.9 +/- 7.3 nm
ol/g). To examine the time-course of the release, further experiments
were performed at constant perfusion flow with energy metabolism block
ed by cyanide together with removal of glucose from the perfusion buff
er. This condition resulted in a nearly simultaneous release of adenos
ine and noradrenaline from the hearts. The beta-adrenoceptor blocking
agents atenolol and bisoprolol postponed the release of adenosine, whe
reas the alpha-antagonists prazosin and yohimbine had no effect on ade
nosine release induced by cyanide. None of the adrenergic receptor blo
ckers affected the release of noradrenaline. The inhibitors of the neu
ronal noradrenaline carrier (uptake(1)) desipramine, oxaprotiline, and
cocaine suppressed the release of noradrenaline during cyanide admini
stration, indicating a carrier-mediated efflux of noradrenaline. Reduc
tion of extracellular noradrenaline by these agents coincided with a d
elay of adenosine release (cumulative release within 20 min-control: 2
51.2 +/- 13.9, desipramine: 172.1 +/- 15.3, oxaprotiline 36.5 +/- 5.8,
cocaine: 111.8 +/- 23.6 nmol/g). Desipramine and cocaine were also us
ed during administration of exogenous noradrenaline in normoxic hearts
, to confirm specificity of their action. Under these conditions, desi
pramine and cocaine increased the concentration of extracellular norad
renaline, which was paralleled by an augmentation of adenosine release
into the effluent of the hearts (control: 32 +/- 8, desipramine: 103
+/- 15, cocaine: 79 +/- 9 nmol/g). Comparable to the findings in energ
y depleted hearts, only the administration of beta-antagonists suppres
sed adenosine formation during noradrenaline infusion in normoxic hear
ts, In conclusion, in ischemic hearts adenosine formation is accelerat
ed by the release of endogenous noradrenaline acting primarily via bet
a-adrenergic receptor stimulation.